Key result
Acid-labile subunit (ALS) measurement was less accurate than IGF-I or IGFBP-3 in diagnosing growth hormone deficiency and added little diagnostic information overall.
Why the study?
Does measurement of acid-labile subunit (ALS) improve diagnostic accuracy compared to IGF-I and IGFBP-3 in pediatric patients with growth or eating disorders?
Observational (n=80)
Does measurement of acid-labile subunit (ALS) improve diagnostic accuracy compared to IGF-I and IGFBP-3 in pediatric patients with growth or eating disorders?
Measurement of acid-labile subunit (ALS) does not provide additional diagnostic value over IGF-I and IGFBP-3 in pediatric patients with growth or eating disorders.
Answers are grounded in this paper and cite their sources.
ALS adds no diagnostic value over IGF-I/IGFBP-3 in children; leaves open any niche role in select growth disorders.
OBJECTIVE: To analyze the possible utility of measuring acid-labile subunit (ALS) in some types of pathologies in which the IGF system is altered and to compare it with the clinical implications of measurements of other components of this axis. DESIGN AND METHODS: We studied serum ALS concentrations in 20 children with normal variants of short stature (NVSS) at diagnosis and 24 with growth hormone deficiency (GHD), 18 obese patients and 18 girls with anorexia nervosa at diagnosis and during a follow-up period. RESULTS: In patients with GHD and anorexia nervosa, mean ALS concentrations were significantly reduced, but there was a high percentage of overlap with control values. At diagnosis, ALS concentrations were normal in obese patients and children with NVSS. During follow-up, these values normalized in children with GHD who were treated with GH, tended to normalize in those with anorexia nervosa who showed weight gain, and did not change in obese children upon weight loss. However, ALS measurement was less accurate than that of IGF-I or IGF binding protein (IGFBP)-3 in diagnosis of GHD. The correlations found between ALS and some IGF system components at diagnosis either decreased or were non-significant during follow-up of these clinical conditions. CONCLUSION: ALS adds little information to that obtained with IGF-I and IGFBP-3 determinations.
No takes yet. Share an insight, caveat, or question.
Barrios et al. (2001) conducted an observational in Growth or eating disorders (n=80). Acid-labile subunit (ALS) measurement vs. IGF-I or IGFBP-3 measurement was evaluated on Diagnostic accuracy of ALS compared to IGF-I or IGFBP-3. Acid-labile subunit (ALS) measurement was less accurate than IGF-I or IGFBP-3 in diagnosing growth hormone deficiency and added little diagnostic information overall.
Synapse has enriched 10 related papers. Consider them for comparative context: